Updates About the Expanded Access Program for MN-166 in ALS

Program to provide investigational drug to ALS patients who would otherwise be ineligible for clinical trials SAN JOSE, Calif., June 29, 2026 /PRNewswire/ -- WideTrial is pleased to share that the Expanded Access Program it launched in 2025, Scalable Expanded Access with Analysis of...